Melaleuca alternifolia nanoparticles against Candida species biofilms

M E Souza1, L Q S Lopes1, P C Bonez2

  • 1Laboratory of Microbiological Research, Centro Universitário Franciscano, Santa Maria, Brazil; Laboratory of Nanotechnology, Post Graduate Program of Nanosciences, Centro Universitário Franciscano, Santa Maria, Brazil.

Microbial Pathogenesis
|January 17, 2017
PubMed

Insights

Tea Tree Oil (TTO) nanoparticles effectively combat Candida biofilms, a significant challenge in immunosuppressed patients. This study demonstrates TTO nanoparticles reduce biofilm biomass and key components, offering a promising antimicrobial strategy.

Area of Science:

  • Mycology
  • Nanotechnology
  • Pharmaceutical Sciences

Background:

  • Candida infections pose significant morbidity and mortality risks, particularly in immunosuppressed individuals.
  • Antimicrobial resistance and biofilm formation by Candida species complicate treatment strategies.
  • Tea Tree Oil (TTO) exhibits antimicrobial and antibiofilm properties but suffers from poor solubility and high volatility.

Purpose of the Study:

  • To evaluate the in vitro antibiofilm activity of TTO nanoparticles against various Candida species.
  • To characterize TTO oil and its derived nanoparticles.
  • To quantify the impact of TTO nanoparticles on biofilm components and biomass.

Main Methods:

  • Characterization of TTO oil composition (e.g., Terpinen-4-ol, Terpinene isomers, 1,8-Cineole) and TTO nanoparticles (pH, size, PDI, zeta potential).
  • In vitro assessment of antibiofilm activity against multiple Candida species.
  • Quantification of biofilm exopolysaccharides, proteins, and total biomass.
  • Microscopic visualization of biofilm reduction using the Calcofluor White method.

Main Results:

  • TTO oil composition confirmed adherence to ISO 4730 standards.
  • TTO nanoparticles exhibited favorable characteristics (pH 6.3, size ~158 nm, PDI ~0.21, zeta potential ~-8.7 mV).
  • Both TTO and TTO nanoparticles significantly reduced biofilm formation across all tested Candida species, decreasing protein and exopolysaccharide levels.

Conclusions:

  • TTO nanoparticles demonstrate potent in vitro antibiofilm activity against diverse Candida species.
  • Nanoparticle formulation overcomes TTO's limitations, enhancing its therapeutic potential.
  • TTO nanoparticles represent a promising alternative for managing Candida biofilm infections, especially in vulnerable patient populations.